| AKI | Acute kidney injury |
| ALI | Acute lung injury |
| ARDS | Acute Respiratory Distress Syndrome |
| AUC | Area under the curve |
| AZM | Azithromycin |
| CSTH | Critical temperature of solution in hexane |
| CST | Critical temperature of solution |
| DED | Dry eye disease |
| F4H5 | Perfluorobutylpentane |
| F6H8 | Perfluorohexyloctane |
| F6H8-cEM | Perfluorohexyloctane-containing emulsions |
| F6H8S5 | perfluorohexyloctane/polydimethylsiloxane |
| F6H10 | Perfluorohexyldecane |
| HBO | Hyperbaric hyperoxygenation |
| H2O | Water |
| H&E | Hematoxylin and eosin (staining) |
| mAb | Monoclonal antibodies |
| MCT | Medium-Chain Triglyceride |
| MGD | Myoboma gland dysfunction |
| MMAD | Mass Median Aerodynamic Diameter |
| mPas | Millipascal |
| MRT | Magnetic resonance tomography |
| 19F-MRI | 19F magnetic resonance imaging |
| NBO | Normobaric hyperoxygenation |
| NMR | Nuclear magnetic resonance |
| 19F-NMR | 19F nuclear magnetic resonance |
| PET | Positron emission tomography |
| PFCs | Perfluorcarbons |
| PFCL | Perfluorocarbon liquids |
| PFD | Perfluorodecaline |
| PFO | Perfluorooctane |
| PFOB | Perfluoroctylbromide |
| PLV | Partial liquid ventilation |
| PTFE | Polytetrafluoroethylene |
| PVR | Proliferative vitreoretinopathy |
| RES | Reticuloendothelial system |
| SFAs | Semifluorinated alkanes |
| S75 | Lecithin |
| SH | Sodium hyaluronate |
| TLV | Total liquid ventilation |
| VEGF | Vascular endothelial growth factor |